General Statement of Disclosure:

CONSULTING FEES/HONORARIA: AMGEN(SIGNIFICANT), Kowa(MODEST), Sanofi/Regeneron(SIGNIFICANT), Novo-Nordisk(MODEST), Merck(MODEST), AstraZeneca Pharmaceuticals(MODEST), Ache(MODEST), PTC(MODEST), Novartis Corporation(MODEST), Abbott Laboratories(MODEST), Roche(MODEST) SPEAKER'S BUREAU: Pfizer(MODEST), Libbs (SIGNIFICANT), GETZ Pharma(MODEST), Amryt(MODEST) RESEARCH/RESEARCH GRANTS: Esperion(SIGNIFICANT)

View Full Disclosure